BANFF, AB, June 3, 2014 /CNW/ - The Canadian Foundation for Healthcare Improvement will announce funding and support for 15 teams from across Canada to lead projects tackling the inappropriate use of antipsychotic medications in dementia care. The teams of healthcare providers and administrators from healthcare organizations in seven provinces and one territory have been accepted into CFHI's Reducing Antipsychotic Medication Use in Long Term Care collaborative.
8:00 a.m. (MDT): CFHI President Maureen O'Neil will announce the teams in her remarks opening the Spreading Healthcare Innovations in a Land of Pilot Projects workshop in Banff, Alberta. Media availability following remarks.
8:00 a.m. – 6:00 p.m. (MDT): Interviews with spokespeople from project teams can be scheduled by contacting CFHI's media contact. All teams will have members taking part in the workshop. Photo opportunity at 9:45 a.m.
Date: Wednesday, June 4, 2014
Location: Van Horne Room, Fairmont Banff Springs, Banff, AB
One in three long term care residents in Canada is on antipsychotic medication without a diagnosis of psychosis from a doctor. CFHI is providing funding and other support to a wide range of organizations to implement new approaches or to scale up existing work to reduce antipsychotic rates.
The Canadian Foundation for Healthcare Improvement is a not-for-profit organization dedicated to accelerating healthcare improvement by working with provinces, territories and other healthcare partners to promote efficient healthcare that delivers better outcomes. With a $10 million annual federal investment, CFHI supports the development of innovations that could save provincial-territorial healthcare budgets over $1 billion per year. CFHI is funded through an agreement with the Government of Canada.
SOURCE: Canadian Foundation for Healthcare Improvement
For further information: Graeme Wilkes, Senior Director, Communications & Government Relations, Canadian Foundation for Healthcare Improvement, C: 613-698-7538, E: email@example.com